The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
89Bio Inc Common 282559103   11,264,517 967,742 SH   SOLE   967,742 0 0
Adaptimmune Therapeutics plc Sponsored ADR 00653A107   8,051,541 5,095,912 SH   SOLE   5,095,912 0 0
Akero Therapeutics Inc Common 00973Y108   8,409,660 332,924 SH   SOLE   332,924 0 0
ALX Oncology Holdings Inc. Common 00166B105   14,143,452 1,268,471 SH   SOLE   1,268,471 0 0
Amicus Therapeutics Inc. Common 03152W109   8,469,467 718,970 SH   SOLE   718,970 0 0
Avadel Pharmaceuticals PLC Sponsored ADR 05337M104   14,713,707 871,149 SH   SOLE   871,149 0 0
Axsome Therapeutics, Inc. Common 05464T104   9,107,335 114,127 SH   SOLE   114,127 0 0
Compass Therapeutics, Inc. Common 20454B104   3,903,376 1,971,402 SH   SOLE   1,971,402 0 0
Crinetics Pharmaceuticals Inc. Common 22663K107   22,496,324 480,588 SH   SOLE   480,588 0 0
Cullinan Oncology, Inc. Common 230031106   130,326,487 7,648,268 SH   SOLE   7,648,268 0 0
Disc Medicine Inc Common 254604101   6,897,101 110,779 SH   SOLE   110,779 0 0
Edgewise Therapeutics Inc Common 28036F105   8,048,564 441,259 SH   SOLE   441,259 0 0
Fulcrum Therapeutics Inc Common 359616109   10,734,300 1,137,108 SH   SOLE   1,137,108 0 0
Geron Corporation Common 374163103   34,569,728 10,475,675 SH   SOLE   10,475,675 0 0
Immatics NV Common N44445909   4,153,941 395,237 SH   SOLE   395,237 0 0
Insmed Incorporated Common 457669307   14,400,441 530,794 SH   SOLE   530,794 0 0
Intellia Therapeutics, Inc. Common 45826J105   11,900,771 432,598 SH   SOLE   432,598 0 0
Iovance Biotherapeutics Inc Common 462260100   32,604,000 2,200,000 SH   SOLE   2,200,000 0 0
Kalvista Pharmaceuticals Inc Common 483497103   9,022,163 760,722 SH   SOLE   760,722 0 0
iTeos Therapeutics, Inc. Common 46565G104   23,814,663 1,745,943 SH   SOLE   1,745,943 0 0
Madrigal Pharmaceuticals inc Common 558868105   16,395,989 61,399 SH   SOLE   61,399 0 0
Moonlake Immunotherapeutics Class A Ord 61559X104   14,870,592 296,050 SH   SOLE   296,050 0 0
MORPHIC HOLDING INC Common 61775R105   11,451,722 325,333 SH   SOLE   325,333 0 0
Natera Inc Common 632307104   15,768,893 172,413 SH   SOLE   172,413 0 0
Olema Pharmaceuticals, Inc. Common 68062P106   22,115,771 1,953,690 SH   SOLE   1,953,690 0 0
REGENXBIO Inc. Common 75901B107   11,569,073 549,078 SH   SOLE   549,078 0 0
Relay Therapeutics Inc. Common 75943R102   6,905,741 832,017 SH   SOLE   832,017 0 0
Repare Therapeutics, Inc. Common 760273102   7,723,689 1,639,849 SH   SOLE   1,639,849 0 0
Revolution Medicines, Inc. Common 76155X100   8,805,784 273,217 SH   SOLE   273,217 0 0
Sutro Biopharma, Inc. Common 869367102   23,145,897 4,096,619 SH   SOLE   4,096,619 0 0
Trevi Therapeutics Inc Common 89532M101   4,626,312 1,340,960 SH   SOLE   1,340,960 0 0
Ultragenyx Pharmaceutical Inc Common 90400D108   11,466,597 245,590 SH   SOLE   245,590 0 0
Verve Therapeutics, Inc Common 92539P101   8,474,805 638,163 SH   SOLE   638,163 0 0
VIKING THERAPEUTICS INC Common 92686J106   12,300,000 150,000 SH   SOLE   150,000 0 0
Viridian Therapeutics Inc Common 92790C104   10,751,315 614,010 SH   SOLE   614,010 0 0
Xeris Biopharma Holdings Inc Common 98422E103   9,207,956 4,166,496 SH   SOLE   4,166,496 0 0
Werewolf Therapeutics, Inc. Common 95075A107   15,474,311 2,388,011 SH   SOLE   2,388,011 0 0
Zentalis Pharmaceuticals, Inc. Common 98943L107   23,895,044 1,516,183 SH   SOLE   1,516,183 0 0